Yesterday, April 11, 2016, 34 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $60.52 to $14,857,800.00.

Highlighted Stocks Traded by Insiders:

Cognizant Technology Solutions (CTSH) - FREE Research Report

McLoughlin Karen, who is Chief Financial Officer at Cognizant Technology Solutions, sold 880 shares at $61.01 on April 11, 2016. Following this transaction, the Chief Financial Officer owned 40,741 shares meaning that the stake was reduced by 2.11% with the 880-share transaction.

The shares most recently traded at $60.00, down $1.01, or 1.68% since the insider transaction. Historical insider transactions for Cognizant Technology Solutions go as follows:

  • 4-Week # shares sold: 30,973
  • 12-Week # shares sold: 31,800
  • 24-Week # shares bought: 7,500
  • 24-Week # shares sold: 72,701

The average volume for Cognizant Technology Solutions has been 4.9 million shares per day over the past 30 days. Cognizant Technology Solutions has a market cap of $37.3 billion and is part of the technology sector and computer software & services industry. Shares are up 2.58% year-to-date as of the close of trading on Wednesday.

Cognizant Technology Solutions Corporation provides information technology (IT), consulting, and business process services worldwide. The company operates through four segments: Financial Services, Healthcare, Manufacturing/Retail/Logistics, and Other. The company has a P/E ratio of 23.1. Currently, there are 17 analysts who rate Cognizant Technology Solutions a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on CTSH - FREE

TheStreet Quant Ratings rates Cognizant Technology Solutions as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, reasonable valuation levels, growth in earnings per share and increase in net income. We feel its strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full Cognizant Technology Solutions Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Eli Lilly and (LLY) - FREE Research Report

Lilly Endowment Inc, who is 10% Owner at Eli Lilly and, sold 200,000 shares at $74.29 on April 11, 2016. Following this transaction, the 10% Owner owned 127.7 million shares meaning that the stake was reduced by 0.16% with the 200,000-share transaction.

The shares most recently traded at $74.59, up $0.30, or 0.4% since the insider transaction. Historical insider transactions for Eli Lilly and go as follows:

  • 4-Week # shares bought: 3,170
  • 4-Week # shares sold: 15,230
  • 12-Week # shares bought: 3,170
  • 12-Week # shares sold: 20,776
  • 24-Week # shares bought: 3,170
  • 24-Week # shares sold: 1.1 million

The average volume for Eli Lilly and has been 5.3 million shares per day over the past 30 days. Eli Lilly and has a market cap of $80.8 billion and is part of the health care sector and drugs industry. Shares are down 11.27% year-to-date as of the close of trading on Wednesday.

Eli Lilly and Company discovers, develops, manufactures, and markets pharmaceutical products worldwide. It operates through two segments, Human Pharmaceutical Products and Animal Health Products. The stock currently has a dividend yield of 2.79%. The company has a P/E ratio of 32.3. Currently, there are 9 analysts who rate Eli Lilly and a buy, 1 analyst rates it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on LLY - FREE

TheStreet Quant Ratings rates Eli Lilly and as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures and growth in earnings per share. However, as a counter to these strengths, we find that we feel that the company's cash flow from its operations has been weak overall. Get the full Eli Lilly and Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

General Growth Properties (GGP) - FREE Research Report

Abu Dhabi Investment Authority, who is Shareholder at General Growth Properties, sold 936 shares at $28.81 on April 11, 2016. Following this transaction, the Shareholder owned 38.5 million shares meaning that the stake was reduced by 0% with the 936-share transaction.

The shares most recently traded at $28.76, down $0.05, or 0.16% since the insider transaction. Historical insider transactions for General Growth Properties go as follows:

  • 4-Week # shares bought: 19,500
  • 4-Week # shares sold: 22,400
  • 12-Week # shares bought: 19,500
  • 12-Week # shares sold: 22,400
  • 24-Week # shares bought: 19,500
  • 24-Week # shares sold: 197,452

The average volume for General Growth Properties has been 5.4 million shares per day over the past 30 days. General Growth Properties has a market cap of $25.6 billion and is part of the financial sector and real estate industry. Shares are up 6.39% year-to-date as of the close of trading on Wednesday.

General Growth Properties, Inc is an equity real estate investment trust. The firm invests in the real estate markets of the United States. It engages in owning, managing, leasing, and redeveloping high-quality regional malls. General Growth Properties, Inc is based in Chicago, Illinois. The stock currently has a dividend yield of 2.62%. The company has a P/E ratio of 20.3. Currently, there are 8 analysts who rate General Growth Properties a buy, no analysts rate it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on GGP - FREE

TheStreet Quant Ratings rates General Growth Properties as a buy. The company's strengths can be seen in multiple areas, such as its notable return on equity, expanding profit margins and good cash flow from operations. We feel its strengths outweigh the fact that the company has had sub par growth in net income. Get the full General Growth Properties Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.